Latest Breaking News On - Rouco molina - Page 4 : comparemela.com

GigaGen Awarded Contract by U S Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens

GigaGen Awarded Contract by U S Department of Defense to Discover Synthetic Human Antibody Treatments for High-Priority Toxins and Pathogens
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaCarter kellerMonica rouco molinaUs department of defenseLifesci communicationsProgram executive office for chemicalGigagen incGrifols press officeNuclear defenseSpanish stock exchangeAmgen incJoint program executive officePrototype agreementNorth americaMiddle east

GigaGen Awarded Contract by U S Department of Defense to

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immune.

United statesComunidad autonoma de catalunaCarter kellerMonica rouco molinaUs department of defenseLifesci communicationsProgram executive office for chemicalGigagen incGrifols press officeNuclear defenseSpanish stock exchangeAmgen incJoint program executive officePrototype agreementNorth americaMiddle east

X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

X4 Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPaula raganRouco molinaEuropean hematology associationExchange commissionUs food drug administrationDevelopment rd expensesLifesci communicationsPharmaceuticals incChief executive officerHercules capitalData updateOrphan drug designationDrug administrationCash equivalentsRestricted cash

Revolo Biotherapeutics Awarded Innovation Passport for 1805 in the United Kingdom for the Treatment of Moderate to Severe Rheumatoid Arthritis

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United kingdomCity ofJonathan rigbyRevolo biotherapeuticRevolo biotherapeuticsRevolo bioMarylyn rigbyMonica rouco molinaRevolo biotherapeutics bioPublic reference groupCompany contactToxicology centreRegulatory agencyNational institute for healthLifesci communicationsSteering group

DURECT : Appoints Timothy M Papp as Chief Financial Officer - Form 8-K

Michael Morabito, PhD, Solebury Trout, +1-646-378-2928, mmorabito@soleburytrout.com Media Contact - Mónica Rouco Molina, PhD, LifeSci Communications, +1-929-469-3850,. | July 5, 2022

United statesTimothym pappRodman renshawRouco molinaMichael morabitoJamese brownDrug administrationInnocoll pharmaceuticalsExchange commissionCorporation appoints timothym pappWharton school of businessLifesci communicationsInnocoll pharmaceuticals ltdCorporation nasdaqDuke universityAppoints timothy